Phillips-Medisize Corporation: Company Profile

Background

Overview

Phillips-Medisize, a Molex company, is a leading global contract development and manufacturing organization (CDMO) specializing in the design, development, and manufacturing of pharmaceutical, medical device, and diagnostic products. Established in 1964, the company has grown to become a significant player in the healthcare manufacturing sector, offering end-to-end solutions from initial concept through to high-volume production.

Mission and Vision

Phillips-Medisize is committed to delivering innovative, high-quality manufacturing solutions that enhance patient outcomes and improve lives. The company's vision is to be the preferred partner for pharmaceutical, medical device, and diagnostic companies, providing comprehensive services that accelerate product development and market entry.

Primary Area of Focus

The company focuses on complex drug delivery devices, diagnostic consumables, and custom components, serving various markets, including defense and consumer products. Phillips-Medisize emphasizes continuous improvement through its Principle Based Management™ framework, ensuring high-quality standards and operational excellence.

Industry Significance

As a CDMO, Phillips-Medisize plays a crucial role in the healthcare industry by enabling companies to bring innovative medical products to market efficiently and effectively. Its expertise in complex manufacturing processes and regulatory compliance makes it a valuable partner for organizations seeking to develop and produce medical devices and pharmaceutical products.

Key Strategic Focus

Core Objectives

Innovation: Develop and implement cutting-edge manufacturing technologies to meet evolving industry needs.

Quality: Maintain high standards of quality control and regulatory compliance across all operations.

Customer Collaboration: Work closely with clients to accelerate product development and market entry.

Specific Areas of Specialization

Drug Delivery Devices: Design and manufacture devices such as insulin pens, inhalers, and other specialty drug delivery systems.

Diagnostic Consumables: Produce components for diagnostic devices, including glucose meters and other point-of-care testing products.

Custom Components: Offer tailored solutions for complex medical device components, integrating design, molding, and automation.

Key Technologies Utilized

Advanced Injection Molding: Employ sophisticated molding techniques to produce high-precision components.

Automated Assembly: Utilize automated systems to enhance production efficiency and consistency.

Connected Health Platforms: Develop cloud-based platforms to support connected health solutions, integrating devices with data analytics.

Primary Markets Targeted

Pharmaceutical Companies: Provide manufacturing solutions for drug delivery devices and packaging.

Medical Device Manufacturers: Offer services for the production of diagnostic and therapeutic devices.

Diagnostic Companies: Support the development and manufacturing of diagnostic tools and consumables.

Financials and Funding

Funding History

Phillips-Medisize has experienced significant growth, with annual sales exceeding $700 million, primarily from drug delivery, medical device, and diagnostic products.

Recent Funding Rounds

In August 2016, Molex, a global manufacturer of interconnect solutions, acquired Phillips-Medisize, integrating it into Molex's portfolio.

Notable Investors

Prior to the acquisition by Molex, Phillips-Medisize was a portfolio company of Golden Gate Capital, a private equity investment firm.

Utilization of Capital

The acquisition by Molex has enabled Phillips-Medisize to leverage Molex's global resources, enhancing its manufacturing capabilities and expanding its reach in the medical solutions market.

Pipeline Development

Key Pipeline Candidates

Phillips-Medisize collaborates with clients to develop a range of medical devices and diagnostic products, including:

Drug Delivery Devices: Innovative solutions for insulin delivery, inhalation therapies, and other specialty drug delivery systems.

Diagnostic Devices: Components for point-of-care testing, including glucose meters and diagnostic consumables.

Connected Health Solutions: Platforms integrating medical devices with data analytics to enhance patient care.

Stages of Development

Phillips-Medisize engages in all stages of product development, from initial design and prototyping to clinical trials and commercial-scale manufacturing. The company has expanded its clinical manufacturing capabilities to support the growing drug delivery device market, including dedicated units for cleanroom assembly and molding.

Target Conditions

The company's products address various medical conditions, including diabetes, cardiovascular diseases, and respiratory disorders, aiming to improve patient outcomes through innovative delivery methods and diagnostic tools.

Anticipated Milestones

Phillips-Medisize continues to collaborate with clients to bring new products to market, focusing on accelerating development timelines and ensuring regulatory compliance to meet market demands.

Technological Platform and Innovation

Proprietary Technologies

Connected Health Platform (CHP): A cloud-based system designed to support connected drug delivery devices, biosensors, and regulated mobile medical applications, enhancing data sharing and analytics capabilities.

Significant Scientific Methods

Advanced Injection Molding: Utilizing complex molding techniques to produce high-precision components for medical devices.

Automated Assembly: Implementing automated systems to improve production efficiency and consistency.

Data Analytics: Employing analytics to support connected health solutions, integrating devices with data platforms.

Leadership Team

Key Executives

Matt Jennings: Chairman, President, and CEO of Phillips-Medisize. Under his leadership, the company has expanded its capabilities and market presence.

John Horgan: Vice President of Global Sales and Marketing, overseeing strategic initiatives and client relationships.

Leadership Changes

In August 2016, Phillips-Medisize was acquired by Molex, leading to integration into Molex's organizational structure.

Competitor Profile

Market Insights and Dynamics

The global contract development and manufacturing organization (CDMO) market is experiencing growth due to increasing demand for outsourced manufacturing services in the pharmaceutical and medical device sectors. Companies are seeking partners with expertise in complex manufacturing processes and regulatory compliance to bring innovative products to market efficiently.

Competitor Analysis

Key competitors in the CDMO space include:

Schott: A global technology company specializing in advanced materials and components for the pharmaceutical and medical device industries.

Elos Medtech: Provides contract manufacturing services for medical devices, focusing on precision components and assemblies.

Gerresheimer: A leading provider of healthcare packaging and medical devices, offering a range of products and services to the pharmaceutical and healthcare sectors.

Strategic Collaborations and Partnerships

Phillips-Medisize has formed strategic partnerships to enhance its capabilities, including:

Collaboration with InterSystems to develop the Connected Health Platform, integrating healthcare data for connected drug delivery devices and mobile medical applications.

Partnership with Exact Sciences to manufacture components for Cologuard®, a noninvasive colorectal cancer screening test, demonstrating the company's ability to scale production for critical healthcare products.

Operational Insights

Phillips-Medisize's extensive global footprint, with 23 production facilities across the U.S., Europe, and Asia, enables it to offer scalable manufacturing solutions. The company's integration with Molex provides access to advanced electronics and connectivity technologies, enhancing its product offerings.

Strategic Opportunities and Future Directions

Phillips-Medisize continues to focus on expanding its capabilities in connected health solutions, leveraging its expertise in device manufacturing and data analytics. The company aims to strengthen its position in the global market by developing innovative products and forming strategic partnerships to address emerging healthcare needs.